E-cadherin is generally not expressed in brain tumours, except in benign meningiomas (Schwechheimer et al, 1998), whereas N-cadherin and β-catenin are detectable at cell–cell junctions in malignant astrocytic tumours (Utsuki et al, 2002). Here, CDH1 is linked to benign meningioma.